| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/02/1997 | EP0769968A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 05/02/1997 | EP0769964A2 Cck antibodies used to improve feed efficiency |
| 05/02/1997 | EP0769963A1 Polyepitope vaccines |
| 05/02/1997 | EP0769955A1 Non-antigenic amine derived polymers and polymer conjugates |
| 05/02/1997 | EP0769952A1 Chicken infectious anemia virus vaccine |
| 05/02/1997 | EP0769942A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 05/02/1997 | EP0769932A1 Implanted device containing tumor cells for the treatment of cancer |
| 05/02/1997 | EP0627006B1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
| 05/02/1997 | EP0500917B1 Recombinant herpes simplex viruses vaccines and methods |
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015600A1 Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates |
| 05/01/1997 | WO1997015597A1 HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015331A1 Methods of preserving microorganisms |
| 05/01/1997 | WO1997015327A1 Methods of treating established colitis using antibodies against il-12 |
| 05/01/1997 | WO1997015326A1 Remedy for hepatitides |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015324A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1997015316A1 Conjugates of gonadotropin releasing hormone |
| 05/01/1997 | WO1997015310A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | WO1997015289A1 Solubilisation methods |
| 05/01/1997 | WO1997015243A1 Induction of immunological tolerance |
| 05/01/1997 | WO1997015195A1 Hybrid matrix implants and explants |
| 05/01/1997 | CA2235599A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates |
| 05/01/1997 | CA2235509A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | CA2235495A1 Methods of preserving microorganisms |
| 05/01/1997 | CA2235487A1 Solubilisation methods |
| 05/01/1997 | CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 04/30/1997 | CN1148505A Activated immune globulin |
| 04/30/1997 | CN1148493A High-energy oxygen anti-cancer guiding synthetic agent |
| 04/29/1997 | US5625049 Nucleic acids encoding human astrovirus serotype 2 |
| 04/29/1997 | US5625039 Anti-human IgE monoclonal antibodies |
| 04/29/1997 | US5625034 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/29/1997 | US5624836 DNA encoding bovine pancreatic cholesterol esterase |
| 04/29/1997 | US5624830 Selectivity killing mammalian host cells in vitro |
| 04/29/1997 | US5624827 DNA sequences encoding the plant toxin gelonin |
| 04/29/1997 | US5624823 DNA encoding procine interleukin-10 |
| 04/29/1997 | US5624821 Antibodies with altered effector functions |
| 04/29/1997 | US5624804 Glycosylation of protein such as albumin for medical diagnosis |
| 04/29/1997 | US5624795 Isolation and characterization of a novel chimpanzee lentivirus, designated simian immunodeficiency virus isolate cpz-ant |
| 04/29/1997 | US5624671 Method for increasing egg production rate, egg weight or eggshell strength by administering a composition containing the plants Rosa roxburghii, Artemisiae argyi folium and Brassica oleracea var. capitata L. |
| 04/28/1997 | CA2185407A1 Sustainable chick cell line infected with marek's disease virus |
| 04/28/1997 | CA2185406A1 Improvements in sustainable cell line for the production of marek's disease vaccines |
| 04/24/1997 | WO1997014964A2 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014801A1 Novel cell surface protein compounds |
| 04/24/1997 | WO1997014800A1 Novel saliva binding protein |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014796A1 Monoclonal antibody br110 and uses thereof |
| 04/24/1997 | WO1997014795A1 Tumor associated polypeptides with carboxyl-terminal alanine-proline, proline-proline or glycine-proline and antibodies thereto |
| 04/24/1997 | WO1997014782A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/24/1997 | WO1997014719A1 A bifunctional or bivalent antibody fragment analogue |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014442A1 Hormone immunomodulated induction of mucosal immune responses |
| 04/24/1997 | WO1997014437A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | WO1997014436A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | WO1997014434A1 Influenza vaccine |
| 04/24/1997 | WO1997014433A1 Chicken interleukin-15 and uses thereof |
| 04/24/1997 | WO1997014426A1 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014306A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1997007823A3 Compositions and their uses |
| 04/24/1997 | WO1997005267A3 Mucosal delivery of polynucleotides |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/24/1997 | CA2235257A1 Influenza vaccine |
| 04/24/1997 | CA2235245A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | CA2235168A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | CA2234088A1 Patient-specific immunoadsorbents for extracorporal apheresis and methods for their preparation |
| 04/24/1997 | CA2233848A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/23/1997 | EP0769147A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768893A1 Polynucleotide vaccine for papillomavirus |
| 04/23/1997 | EP0768890A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 04/23/1997 | EP0655927B1 Interleukin-4 stimulated t lymphocyte cell death |
| 04/23/1997 | EP0550477B1 Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 04/23/1997 | CN1148343A Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 04/23/1997 | CN1147962A Tech. for subjecting human hepatitis virus to be carried by non-natural host animal |
| 04/22/1997 | US5623057 Pneumococcal polysaccharide conjugate vaccine |
| 04/22/1997 | US5623056 Immunomodulators |
| 04/22/1997 | US5622933 Multiple branch peptide constructions for use against HIV |
| 04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
| 04/22/1997 | US5622929 Anthracycline antibiotic; antitumor agent binds with a target cell |
| 04/22/1997 | US5622861 Recombinant DNA encoding hepatitis A virus receptor |
| 04/22/1997 | US5622706 Synthetic polypeptide comprising amino acid sequence of mature stx gene; accellular vaccines |
| 04/22/1997 | US5622705 Insertion nucleotide sequence into cell to stimulate immuneresponse |
| 04/22/1997 | US5622703 Immunodominant sites of HTLV-I envelope protein |
| 04/22/1997 | US5622702 Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | US5622700 Administering initial dosage of antibody, subsequent intermittent dosing |
| 04/17/1997 | WO1997013860A1 Neisseria meningitidis subunit tbp2 |
| 04/17/1997 | WO1997013858A2 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |